MedPath

Study to evaluate relation between side effects of first linechemotherapy in breast cancer patients with Prakruti.

Not Applicable
Conditions
Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Registration Number
CTRI/2021/10/037041
Lead Sponsor
College of Ayurved and Research Centre Akurdi Pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Breast cancer patients receiving Chemotherapy.

Exclusion Criteria

Breast cancer patients receiving Chemotherapy but in very critical condition.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Conclusion will be strictly based on statistical analysisTimepoint: Every 6 months
Secondary Outcome Measures
NameTimeMethod
Which prakruti has more side effects of first line of chemotherapy in breast cancer.Timepoint: Every 6 months
© Copyright 2025. All Rights Reserved by MedPath